Circassia Group is a medical devices business based in the US. Circassia Group shares (CSSPF) are listed on the OTCGREY and all prices are listed in US Dollars. Circassia Group employs 92 staff and has a trailing 12-month revenue of around $36.8 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.75 |
|---|---|
| 52-week range | $0.47 - $0.76 |
| 50-day moving average | $0.75 |
| 200-day moving average | $0.76 |
| Wall St. target price | N/A |
| PE ratio | 25 |
| Dividend yield | $0.01 (1.68%) |
| Earnings per share (TTM) | $0.03 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.75 from 2024-09-04
| 1 week (2024-08-30) | 0.75 |
|---|---|
| 1 month (2024-08-06) | 0.75 |
| 3 months (2024-06-02) | N/A |
| 6 months (2024-03-02) | N/A |
| 1 year (2023-09-02) | N/A |
|---|---|
| 2 years (2022-09-02) | N/A |
| 3 years (2021-09-03) | 56.25% |
| 5 years (2019-09-02) | N/A |
Valuing Circassia Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Circassia Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Circassia Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Circassia Group shares trade at around 25x recent earnings.
Circassia Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.3 million.
The EBITDA is a measure of a Circassia Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $36.8 million |
|---|---|
| Operating margin TTM | 8.89% |
| Gross profit TTM | $22.2 million |
| Return on assets TTM | 3.03% |
| Return on equity TTM | 11.47% |
| Profit margin | 29.08% |
| Book value | $0.20 |
| Market Capitalization | $379.3 million |
TTM: trailing 12 months
We're not expecting Circassia Group to pay a dividend over the next 12 months.
Over the last 12 months, Circassia Group's shares have ranged in value from as little as $0.4736 up to $0.7567. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCGREY average) beta is 1, while Circassia Group's is 0.907. This would suggest that Circassia Group's shares are less volatile than average (for this exchange).
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. .
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.